论文部分内容阅读
目的观察稳心颗粒联合西药治疗冠心病心律失常的临床疗效。方法将114例冠心病心律失常患者随机分为两组,对照组使用单纯西药治疗,治疗组在对照组基础上加用稳心颗粒治疗。结果治疗组总有效率明显高于对照组(P<0.05);治疗组PR间期、QTc间期以及QRS波时限变化优于对照组(P<0.05)。两组均无不良反应。结论对冠心病心律失常选择稳心颗粒联合西药治疗所取得的临床效果比较理想,通过进行治疗患者临床有效率提高明显,并且其相关临床症状均得到显著改善,使其生命质量得到十分明显提高,同时不会使不良反应有所增加,可广泛应用于临床治疗。
Objective To observe the clinical effect of Wenxinkeli granule combined with Western medicine in treating arrhythmia of coronary heart disease. Methods 114 patients with coronary heart disease were randomly divided into two groups. The control group was treated with western medicine alone. The treatment group was treated with Wenxin Granule on the basis of the control group. Results The total effective rate of the treatment group was significantly higher than that of the control group (P <0.05). The changes of PR interval, QTc interval and QRS wave duration in the treatment group were better than those in the control group (P <0.05). No adverse reactions in both groups. Conclusion The clinical effect of selecting Wenxin Granule combined with Western medicine is satisfactory. The clinical effective rate of patients treated by this method is obviously improved, and the related clinical symptoms have been significantly improved, which has greatly improved the quality of life. At the same time will not increase the adverse reactions can be widely used in clinical treatment.